[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352073-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-352073-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","nanotechnology-based-immunotherapy-integrating-artificial-intelligence-ai-with-current-strategies-in-combating-brain-cancer-disease","Nanotechnology-based immunotherapy: integrating Artificial Intelligence (AI) with current strategies in combating brain cancer disease","","Brain cancer is a highly challenging malignancy and a leading driver of global morbidity and mortality. Glioblastoma, its most aggressive adult form, remains difficult to treat despite conventional surgery, chemotherapy, and radiotherapy, which can cause severe toxicity and lasting side effects. Immunotherapy may generate durable and specific anti-tumor responses, yet progress is limited by the blood-brain barrier, immunosuppressive tumor microenvironment, and tumor heterogeneity. Nanomedicine enables targeted drug delivery, improving efficacy over free drugs, while nano-vaccines can strengthen antigen presentation and counter immunosuppression. Integrating artificial intelligence (AI) with nanotechnology may further optimize immunotherapy design, targeting, and performance by predicting immunogenicity and immune responses, enhancing formulation and dosing strategies. This review summarizes current nanotechnology-based immunotherapies and emphasizes AI-enabled vaccine development as next-generation approaches to improve outcomes in brain cancer treatment.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nanotechnology-based-immunotherapy-integrating-artificial-intelligence-ai-with-current-strategies-in-combating-brain-cancer-disease/352073/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nanotechnology-based-immunotherapy-integrating-artificial-intelligence-ai-with-current-strategies-in-combating-brain-cancer-disease/352073.png","ImageObject",300,407,{"name":42,"@type":43},"nayy☆","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Why is glioblastoma particularly difficult to treat?","Question",{"text":63,"@type":64},"Glioblastoma is linked to poor prognosis even with surgery, chemotherapy, and radiotherapy, which can produce severe toxicity and long-term side effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What barriers limit immunotherapy success in brain cancer?",{"text":68,"@type":64},"Key obstacles include the blood-brain barrier, the immunosuppressive tumor microenvironment, and tumor heterogeneity.",{"name":70,"@type":61,"acceptedAnswer":71},"How do nanomedicine and nano-vaccines help in brain cancer immunotherapy?",{"text":72,"@type":64},"Nanotechnology supports targeted and efficient drug delivery, and nano-vaccines can enhance antigen presentation, stimulate stronger immune responses, and help overcome tumor-induced immunosuppression.",{"name":74,"@type":61,"acceptedAnswer":75},"How does AI integration improve immunotherapy development?",{"text":76,"@type":64},"AI can predict immunogenicity and immune responses and optimize formulation design and dosing strategies, accelerating development and improving precision and efficiency.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},352073,1790174571,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Roslei et al. Journal of the Egyptian National Cancer Institute (2026) 38:61  \n[https://doi.org/10.1186/s43046-026-00394-3](https://doi.org/10.1186/s43046-026-00394-3)  \nJournal of the Egyptian National Cancer Institute  \nREVIEW Open Access  \nNanotechnology-based immunotherapy: integrating Artificial Intelligence (AI) with current strategies in combating brain cancer disease  \nAlia Syazana Mohd Roslei 1, Hasniza Zaman Huri2, Dyah Ayu Oktavianie A. Pratama3, Ahmad Khusairi Azemi4, Zulhisyam Abdul Kari5, Md Yasin Ina-Salwany6,7, Najihah Mohd Hashim8,9, Mohd Faizal Ghazali10,  \nAbdin Shakirin Mohamad Norpi 11, Muhammad Fauzi Abd Jalil1, Asif Nawaz1, Said AlGhenaimi12, Mazlan Mohamed13 and Muhammad Luqman Nordin 1,14,15*  \nAbstract  \nBrain cancer is one of the most challenging malignancies and a major contributor to worldwide morbidity and mortality. Glioblastoma, the most aggressive adult brain tumor, is associated with poor prognosis despite conventional therapies such as surgery, chemotherapy, and radiotherapy, which often result in severe toxicity and long-term side effects. Immunotherapy holds the potential to provide durable and specific anti-tumor responses; however, its success in brain cancer is hindered by obstacles such as the blood-brain barrier, immunosuppressive tumor microenvironment, and tumor heterogeneity. Nanomedicine offers a powerful approach to overcoming these barriers through targeted and efficient drug delivery. Nanotechnology-based platforms, including lipid-based, polymeric, and inorganic nanoparticles, have demonstrated superior therapeutic efficacy compared to free drugs, with several formulations advancing into clinical trials. Among these, nanotechnology-enabled vaccines represent an emerging frontier, capable of enhancing antigen presentation, stimulating strong immune responses, and overcoming tumor-induced immunosuppression. By combining the precision of nanocarriers with the long-lasting protection of vaccines, nano-vaccines hold great potential to transform brain cancer immunotherapy. Recent studies also suggest that integrating artificial intelligence (AI) with nanotechnology could further enhance the design, targeting, and effectiveness of immunotherapies. Moreover, AI is revolutionizing treatment development by enabling the prediction of immunogenicity, immune responses, and optimizing formulation design and dosing strategies. These advancements collectively accelerate the development and enhance the precision and efficiency of immunotherapy. Hence, this review discusses current nanotechnology-based immunotherapies and highlights the emerging role of integrating AI in vaccine development as next-generation strategies for improving outcomesin brain cancer treatment.  \nKeywords Glioblastoma, Nanotechnology, Immunotherapy, Cancer vaccine, Artificial Intelligence  \n*Correspondence:  \nMuhammad Luqman Nordin [muhammadluqman@um.edu. my](muhammadluqman@um.edu. my)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nRoslei et ","cbCaioWOAi5Imyv4","https://ap.wps.com/l/cbCaioWOAi5Imyv4","pdf",3019189,31,"English","# Introduction\n## Brain cancer burden and risk factors\n## Tumor classification and glioblastoma overview\n# Abstract\n## Challenges in brain cancer immunotherapy\n## Nanotechnology-based immunotherapy and nano-vaccines\n## Role of AI in optimizing treatment development\n# Keywords","[{\"question\":\"Why is glioblastoma particularly difficult to treat?\",\"answer\":\"Glioblastoma is linked to poor prognosis even with surgery, chemotherapy, and radiotherapy, which can produce severe toxicity and long-term side effects.\"},{\"question\":\"What barriers limit immunotherapy success in brain cancer?\",\"answer\":\"Key obstacles include the blood-brain barrier, the immunosuppressive tumor microenvironment, and tumor heterogeneity.\"},{\"question\":\"How do nanomedicine and nano-vaccines help in brain cancer immunotherapy?\",\"answer\":\"Nanotechnology supports targeted and efficient drug delivery, and nano-vaccines can enhance antigen presentation, stimulate stronger immune responses, and help overcome tumor-induced immunosuppression.\"},{\"question\":\"How does AI integration improve immunotherapy development?\",\"answer\":\"AI can predict immunogenicity and immune responses and optimize formulation design and dosing strategies, accelerating development and improving precision and efficiency.\"}]","Nanotechnology-based immunotherapy: integrating Artificial Intelligence (AI) with current strategies in combating brain cancer disease | PDF",1790097562,78,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9771c99749bb8308b9d7791ce02add1.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05a0d8cc51486cf9927660b096f0f531.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ef3718da1f44d927e4777707e0d6004.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bd59860d7a5ef7fc63c5d4bca48248f.webp",980,1306]